“…Similarly, by inhibiting endogenous RNAP or reducing parts of nonessential proteome production, it is possible to balance cell growth and recombinant protein production on resources allocation (Kim, Darlington, Salvador, Utrilla, & Jimenez, 2019). Recently, the evolved T7 phage RNAP inhibitor Gp2 was used in BL21 (DE3) to decouple recombinant protein production from cell growth, which enhanced protein yields up to 3.4‐fold (Stargardt, Feuchtenhofer, Cserjan‐Puschmann, Striedner, & Mairhofer, 2020). Moreover, the resources can be selectively allocated for transcription or translation of target genes by orthogonal molecular elements (Darlington, Kim, Jimenez, & Bates, 2018; Segall‐Shapiro, Meyer, Ellington, Sontag, & Voigt, 2014), which were beneficial to reduce the metabolic burden of the host cells.…”